In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Abbott Laboratories trades below its PERT-weighted fair value of $129.69, implying an 18.6% upside with high confidence. Strong financial health (4.0/5) aligns with robust valuation metrics, though Monte Carlo results reveal significant volatility and a 51.4% downside risk below current price. Valuation suggests potential opportunity tempered by notable risk exposure.